Becton Dickinson and : BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles

FRANKLIN LAKES, N.J., August 14, 2017 - BD (Becton, Dickinson and Company), a leading global medical technology company, has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD BACTEC™ Standard Aerobic and Standard Anaerobic blood culture bottles in plastic. This marks further expansion of the blood culture bottles available in plastic across BD's industry-leading BD BACTEC™ platform.

The new BD BACTEC™ Standard Aerobic and Standard Anaerobic plastic blood culture bottles are designed for customer convenience for the qualitative culture and recovery of aerobic organisms (bacteria & yeast) and anaerobic microorganisms, respectively, from adult blood culture specimens. This latest addition to BD's full spectrum of sepsis and health care associated infection solutions represents BD's continued commitment to meeting customer needs and enhancing laboratory efficiencies. The BD BACTEC™ plastic bottle offerings are smaller and lighter, allowing for easy and safe handling during collection, transport and disposal.

'We are very pleased to announce the expansion of our BD BACTEC™ blood culture plastic bottle offering,' said Steve Conly, Vice President of Microbiology Diagnostics Systems for BD Life Sciences. 'With more than 31.5 million cases of sepsis diagnosed and 5.3 million deaths reported each year worldwide, sepsis continues to place a tremendous health and financial burden on our global health care community. As a global leader in blood culture, expanding our BD BACTEC™ blood culture plastic bottle line demonstrates BD's continued commitment to the fight against Sepsis.'

The BD BACTEC™ blood culture platform, which includes the BD BACTEC™ automated blood culture instrument, resin and lytic media blood culture bottles, has been shown to improve time to detection and recovery of microorganisms, facilitating changes in antibiotic treatment and antibiotic stewardship. For more information, please visit: www.bd.com/ds/ or contact your BD Diagnostics account representative.